Journal profile · Pathology
Pathology - Research and Practice
ISSN 0344-0338 · eISSN 1618-0631 · Urban und Fischer Verlag GmbH und Co. KG · GERMANY · Monthly · Founded 1978
Pathology - Research and Practice: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.7; hybrid open access; APC about USD 2,780; median 79 days to acceptance (100 articles, last 24 months); community-reported acceptance: about 50%; 436 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pathology - Research and Practice is published by Urban und Fischer Verlag GmbH und Co. KG and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation and Circular RNAs in diseases, together about 23.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Pathology - Research and Practice provides accessible coverage of the most recent developments across the entire field of pathology. The Journal publishes traditional morphological studies based on histopathology, including immunohistochemistry with clinical pathological correlations, if sound biostatistical data are provided. The submission of Case Reports is only encouraged for those that provide new information on the pathogenesis of the described disease based on additional molecular biological and genetic investigations. Timely reviews that focus on recent progress in pathology are highly encouraged.A main focus of Pathology - Research and Practice is publication of manuscripts from different clinical disciplines applying molecular genetic and biological techniques and focusing on innovative results, which improve the understanding of causal pathogenesis of human diseases. Investigations for better understanding of cancer diseases and new insights into molecular carcinogenesis, including translational biology of particular cancer entities, are welcome. In this context, manuscripts focusing on new molecular genetic results, but also functional molecular biological data based on cell culture investigations and animal experiments are encouraged. With this strategy, the Journal seeks to contribute to improved understandings of human disease mechanisms.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Mingyang LiPublisher website
Editorial board by country: 15 in mainland China (about 21%); most named United States 17, Mainland China 15, Italy 10, Germany 7, India 6 (73 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology9.6%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology7.4%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology6.8%
- Sarcoma Diagnosis and TreatmentMedicine6.6%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance5.6%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology4.7%
- Lymphoma Diagnosis and TreatmentMedicine4.4%
- Human auditory perception and evaluationEngineering4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.7LetPub ·
- Impact factor (publisher)
- 3.7Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- SJR 2026-06
- 0.68LetPub ·
- SNIP 2026-06
- 0.63LetPub ·
- h-index
- 56LetPub ·
- h-index
- 104OpenAlex ·
- i10-index
- 4,852OpenAlex ·
- 2-year mean citedness
- 4.66OpenAlex ·
- Self-citation rate
- 5.4%LetPub ·
- Share of gold OA articles
- 18.2%LetPub ·
Volume
- Articles per year
- 415LetPub ·
Articles by year OpenAlex count · 11,681 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 278 | 32 | 106 |
| 2025 | 436 | 93 | 1,593 |
| 2024 | 632 | 185 | 4,568 |
| 2023 | 671 | 151 | 8,591 |
| 2022 | 456 | 109 | 5,254 |
| 2021 | 348 | 78 | 4,941 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
79 daysMedian, submission to acceptance · P25–P75 47 days – 140 days
- Acceptance to online
- median 2 days (100 articles)
- Submission to online
- median 81 days
- Sample
- 100 articles with submission and acceptance dates (884 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 47 daysPublisher website ·
- Submission to acceptance
- 92 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,780 / EUR 2,600 / GBP 2,230 / JPY 344,800 | — | — | |
| Publisher website | USD 3,200 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 10,000 words
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted3
- letters to the editorResearch Article: Research Articles should be categorized as either Basic Pathology Research or Clinical Pathology Research, with a maximum length of 10,000 wor…Length not stated
- research articleResearch Article: Research Articles should be categorized as either Basic Pathology Research or Clinical Pathology Research, with a maximum length of 10,000 wor…Length not stated
- review articleResearch Article: Research Articles should be categorized as either Basic Pathology Research or Clinical Pathology Research, with a maximum length of 10,000 wor…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
open access options available Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Urban und Fischer Verlag GmbH und Co. KG
- Country or region
- GERMANY
- Language
- English
- Frequency
- Monthly
- Founded
- 1978
- ISSN
- 0344-0338
- Electronic ISSN
- 1618-0631
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pathology - Research and Practice
What CAS zone is Pathology - Research and Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pathology - Research and Practice is in Zone 4 of Medicine, and in Zone 3 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pathology - Research and Practice?
The latest impact factor listed by LetPub is 3.7; CiteScore 5, h-index 104.
How long does peer review take at Pathology - Research and Practice?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 79 days (interquartile range 47–140 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pathology - Research and Practice?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 10,000 words; Reference style: Numbered, in order of citation; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pathology - Research and Practice based?
Of the 73 board members whose country the journal's board page names, 15 (about 21%) are in mainland China; the countries named most often are United States (17), Mainland China (15) and Italy (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Pathology - Research and Practice?
According to LetPub and DOAJ records, Pathology - Research and Practice is indexed in SCIE and Scopus.
Is Pathology - Research and Practice open access, and what is the APC?
Pathology - Research and Practice is a hybrid journal. For open-access publication: APC about USD 2,780.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .